These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 29470950)

  • 1. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current evidence of contraceptive uptake, pregnancy and continuation rates in young women: a systematic review and Meta-analysis.
    Farah D; Andrade TRM; Di Bella ZIKJ; Girão MJBC; Fonseca MCM
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):492-501. PubMed ID: 33140990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunity, satisfaction, and regret: Trying long-acting reversible contraception in a unique scientific circumstance.
    Burke HM; Packer CA; Spector HL; Hubacher D
    Women Health; 2019 Mar; 59(3):266-280. PubMed ID: 29920171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life of women using the etonogestrel long-acting reversible contraceptive implant after abortion for unplanned pregnancy.
    Caruso S; Vitale SG; Fava V; Pasqua SD; Rapisarda AMC; Cianci S
    Eur J Contracept Reprod Health Care; 2020 Aug; 25(4):251-258. PubMed ID: 32436733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal.
    Sapkota S; Rajbhandary R; Lohani S
    Matern Child Health J; 2017 Sep; 21(9):1713-1723. PubMed ID: 26955996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.
    Chappell CA; Harkoo I; Szydlo DW; Bunge KE; Singh D; Nakabiito C; Mhlanga F; Kamira B; Piper JM; Balkus JE; Hillier SL;
    Contraception; 2019 Sep; 100(3):214-218. PubMed ID: 31226323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial).
    Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K
    BJOG; 2021 Aug; 128(9):1546-1554. PubMed ID: 33988917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-month continuation of reversible contraception.
    O'Neil-Callahan M; Peipert JF; Zhao Q; Madden T; Secura G
    Obstet Gynecol; 2013 Nov; 122(5):1083-1091. PubMed ID: 24104781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
    Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
    BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving cost-neutrality with long-acting reversible contraceptive methods.
    Trussell J; Hassan F; Lowin J; Law A; Filonenko A
    Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Contraceptive Discontinuation Among Black and White Women: Evidence from the Contraceptive CHOICE Project.
    Allsworth JE; Secura GM; Ajibade OO; Peipert JF
    J Womens Health (Larchmt); 2018 May; 27(5):599-606. PubMed ID: 29768114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
    Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
    Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation and satisfaction of reversible contraception.
    Peipert JF; Zhao Q; Allsworth JE; Petrosky E; Madden T; Eisenberg D; Secura G
    Obstet Gynecol; 2011 May; 117(5):1105-1113. PubMed ID: 21508749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C; Dude A; Haider S
    Contraception; 2017 Mar; 95(3):245-250. PubMed ID: 27589883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-year continuation of reversible contraception.
    Diedrich JT; Zhao Q; Madden T; Secura GM; Peipert JF
    Am J Obstet Gynecol; 2015 Nov; 213(5):662.e1-8. PubMed ID: 26259905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Condom use in adolescents and young women following initiation of long- or short-acting contraceptive methods.
    Bastow B; Sheeder J; Guiahi M; Teal S
    Contraception; 2018 Jan; 97(1):70-75. PubMed ID: 29031814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraceptive uptake and compliance after structured contraceptive counseling - secondary outcomes of the LOWE trial.
    Bizjak I; Envall N; Emtell Iwarsson K; Kopp Kallner H; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2024 May; 103(5):873-883. PubMed ID: 38351571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.